Kora Saúde Participações S.A. (BVMF:KRSA3)
Brazil
· Delayed Price · Currency is BRL 8.87
-0.01 (-0.11%)
Inactive · Last trade price
on Apr 14, 2025
Kora Saúde Participações Income Statement
Financials in millions BRL. Fiscal year is January - December.
Millions BRL. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Revenue | 2,268 | 2,260 | 2,047 | 1,262 | 612.29 | Upgrade
|
| Revenue Growth (YoY) | 0.38% | 10.41% | 62.20% | 106.09% | 38.52% | Upgrade
|
| Cost of Revenue | 1,814 | 1,785 | 1,559 | 939.16 | 455.56 | Upgrade
|
| Gross Profit | 454.28 | 474.25 | 487.95 | 322.7 | 156.72 | Upgrade
|
| Selling, General & Admin | 188.67 | 192.81 | 224.67 | 175.48 | 82.59 | Upgrade
|
| Other Operating Expenses | 0.43 | -3.56 | -5.09 | 21.02 | -5.1 | Upgrade
|
| Operating Expenses | 189.1 | 189.25 | 219.59 | 196.5 | 77.5 | Upgrade
|
| Operating Income | 265.18 | 285 | 268.36 | 126.2 | 79.23 | Upgrade
|
| Interest Expense | -358.18 | -345.8 | -302.42 | -106.47 | -52.33 | Upgrade
|
| Interest & Investment Income | 18.6 | 27.06 | 57.84 | 14.62 | 5.52 | Upgrade
|
| Earnings From Equity Investments | 1.9 | 3.92 | 2.62 | 0.84 | -0.1 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | - | 0.08 | - | Upgrade
|
| Other Non Operating Income (Expenses) | -92.82 | -34.97 | -49.16 | -10.19 | - | Upgrade
|
| EBT Excluding Unusual Items | -165.32 | -64.79 | -22.76 | 25.08 | 32.32 | Upgrade
|
| Legal Settlements | -0.48 | 0.02 | -0.47 | 5.77 | - | Upgrade
|
| Other Unusual Items | -8.12 | -69.21 | -66.49 | -28.02 | - | Upgrade
|
| Pretax Income | -173.92 | -133.99 | -89.72 | 2.83 | 32.32 | Upgrade
|
| Income Tax Expense | -5.46 | 24.08 | 4.75 | 57.79 | 14.78 | Upgrade
|
| Earnings From Continuing Operations | -168.45 | -158.07 | -94.47 | -54.96 | 17.54 | Upgrade
|
| Minority Interest in Earnings | -8.82 | -9.56 | -13.12 | -8.76 | -1.67 | Upgrade
|
| Net Income | -177.28 | -167.62 | -107.59 | -63.72 | 15.87 | Upgrade
|
| Net Income to Common | -177.28 | -167.62 | -107.59 | -63.72 | 15.87 | Upgrade
|
| Shares Outstanding (Basic) | 77 | 77 | 77 | 58 | 40 | Upgrade
|
| Shares Outstanding (Diluted) | 77 | 77 | 77 | 58 | 40 | Upgrade
|
| Shares Change (YoY) | 0.03% | 0.32% | 33.80% | 43.75% | 60.96% | Upgrade
|
| EPS (Basic) | -2.29 | -2.17 | -1.40 | -1.11 | 0.40 | Upgrade
|
| EPS (Diluted) | -2.29 | -2.17 | -1.40 | -1.11 | 0.40 | Upgrade
|
| Free Cash Flow | -162.63 | -325.44 | 149 | -83.72 | -13.45 | Upgrade
|
| Free Cash Flow Per Share | -2.10 | -4.21 | 1.93 | -1.45 | -0.34 | Upgrade
|
| Gross Margin | 20.03% | 20.99% | 23.84% | 25.57% | 25.60% | Upgrade
|
| Operating Margin | 11.69% | 12.61% | 13.11% | 10.00% | 12.94% | Upgrade
|
| Profit Margin | -7.82% | -7.42% | -5.26% | -5.05% | 2.59% | Upgrade
|
| Free Cash Flow Margin | -7.17% | -14.40% | 7.28% | -6.64% | -2.20% | Upgrade
|
| EBITDA | 399.09 | 434.02 | 376.62 | 187.13 | 107.22 | Upgrade
|
| EBITDA Margin | 17.59% | 19.21% | 18.40% | 14.83% | 17.51% | Upgrade
|
| D&A For EBITDA | 133.91 | 149.02 | 108.26 | 60.92 | 27.99 | Upgrade
|
| EBIT | 265.18 | 285 | 268.36 | 126.2 | 79.23 | Upgrade
|
| EBIT Margin | 11.69% | 12.61% | 13.11% | 10.00% | 12.94% | Upgrade
|
| Effective Tax Rate | - | - | - | 2039.13% | 45.73% | Upgrade
|
Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.